BIG PHARMA EARNINGS WATCH: ELI LILLY AND NOVO NORDISK
Feb 22, 2024
GLP-1 Weight-Loss Leaders “Blow Past” Wall Street Projections in Q4 2023,… Read More
© 2024 CSRXP- All Rights Reserved
Updates
BIG PHARMA EARNINGS WATCH: MERCK, BRISTOL MYERS SQUIBB AND ABBVIE
Feb 15, 2024
More Big Pharma Giants Report Earnings That Top Wall Street Expectations While… Read More
DOSE OF REALITY: BIG PHARMA CEOS FACE A RECKONING FROM LAWMAKERS AND EXPERTS ON ANTI-COMPETITIVE PRACTICES AND PRICE GOUGING
Feb 12, 2024
Patent Abuse Designed to Extend Monopolies, Block Competition and Keep Prices… Read More
BIG PHARMA EARNINGS WATCH: PFIZER & GLAXOSMITHKLINE
Feb 9, 2024
Big Pharma Giants Continue Q4 Earnings Besting Wall Street Expectations Pfizer… Read More
DOSE OF REALITY: BIG PHARMA BUILDING PATENT THICKETS DISCONNECTED FROM ACTUAL INNOVATION TO CREATE NEW MONOPOLIES ON GLP-1 WEIGHT LOSS DRUGS
Feb 8, 2024
JAMA Analysis Finds Patents for Active Ingredients for Weight Loss Drugs… Read More
Advisory: Panel Discussion on Big Pharma’s Patent Abuse with CSRxP Executive Director Lauren Aronson
Feb 6, 2024
Lawmakers and Experts Will Discuss Solutions to Hold Big Pharma Accountable… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Jan 31, 2024
Big Pharma Giant Kicks Off Q4 Earnings After Hiking Prices More Than 40 Times… Read More
DOSE OF REALITY: BIG PHARMA’S EGREGIOUS PRICING PRACTICES AND ANTI-COMPETITIVE TACTICS DRIVE HIGHER HEALTH CARE COSTS
Jan 30, 2024
Big Pharma Price Hikes, Rising Launch Prices And Patent Abuse Impose Massive… Read More
BIG PHARMA WATCH: AARP REPORT SHINES LIGHT ON SCALE AND COST OF BIG PHARMA’S PRICE HIKES THAT EXCEED INFLATION
Jan 19, 2024
Rx Price Watch Analysis Finds Big Pharma Price Increases Outpaced Inflation… Read More
CSRXP: BIG PHARMA’S JANUARY PRICE HIKES CLIMB TO 775 AS PHARMACEUTICAL INDUSTRY DOUBLES DOWN ON BUSINESS-AS-USUAL APPROACH TO PRICE-GOUGING
Jan 18, 2024
Brand Name Drug Companies’ Price Increases in First Two Weeks of 2024… Read More
BIG PHARMA WATCH: BIG PHARMA DELAYS NEW DRUGS THAT COULD HELP PATIENTS TO BOOST PROFITS
Jan 8, 2024
Report Finds Several Brand Name Drug Companies Waiting to Introduce New… Read More
CSRXP: GSK’S FLOVENT SCHEME DESIGNED TO SIDESTEP ACCOUNTABILITY FOR EGREGIOUS PRICE HIKES
Jan 5, 2024
Big Pharma Giant Switches Popular Brand Name Inhaler to Authorized Generic to… Read More